KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks

Clinical trial NCT00085943 · COMPLETED

Trial details

NCT number: NCT00085943
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HIV Infection Infection, Human Immunodeficiency Virus

Start date: 2004-05-01
Enrollment: 866

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.